Mankind Pharma Limited — Others, 05-05-2025: Disclosure under SEBI Takeover Regulations

Mankind Pharma’s Promoter and Promoter Group, along with persons acting in concert, have confirmed no encumbrance on their shares for the financial year ended March 31, 2025. This underscores their strong confidence and commitment to the company, maintaining shareholding stability without any pledged or lien-marked shares. The broad promoter ownership supports Mankind Pharma’s strategic direction and operational continuity, which is positive for shareholder interests.